Aberrant hepatic MicroRNA expression in nonalcoholic fatty liver disease

Cellular Physiology and Biochemistry

Volumn 34, Issue 6, 2014, Pages 1983-1997

  Feng, Yue Ying ^a,b   Xu, Xiao Qin ^a   Ji, Chen Bo ^c   Shi, Chun Mei ^c   Guo, Xi Rong ^c   Fu, Jun Fen ^a  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Ningbo Women and Children's Hospital   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Deep sequencing; HepG2 cells; Human hepatocyte; miRNA; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID; INTERLEUKIN 6; MICRORNA; MICRORNA 128; MICRORNA 141; MICRORNA 146A; MICRORNA 146B; MICRORNA 150; MICRORNA 152; MICRORNA 181C; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 221; MICRORNA 29B 1; MICRORNA 30C; MICRORNA 322; MICRORNA 342 3P; MICRORNA 429; MICRORNA 455; MICRORNA 499; MICRORNA 503; MICRORNA 741 3P; MICRORNA 880; MICRORNA 881; MICRORNA 9; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARCINOMA CELL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FOCAL ADHESION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; LIPID DIET; LIPID STORAGE; LIVER CELL; LIVER CELL CARCINOMA; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HIGH THROUGHPUT SEQUENCING; INSULIN RESISTANCE; METABOLISM; PATHOLOGY;

RATTUS;

ANIMALS; DIET, HIGH-FAT; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INSULIN RESISTANCE; MICRORNAS; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS;

EID: 84920876554     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366394     Document Type: Article

References (54)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ:The diagnosis and management of non-Alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-2023
2. Kleiner DE, Brunt EM: Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012;32:3-13
3. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM: Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310-315
4. Widhalm K, Ghods E: Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes (Lond) 2010;34:1451-1467
5. Dam-Larsen S, Becker U, Franzmann MB, Larsen K, Christoffersen P, Bendtsen F: Final results of a long-Term, clinical follow-up in fatty liver patients. Scand J Gastroenterol 2009;44:1236-1243
6. Bendtsen F, Dam-Larsen S: Long-Term, clinical follow-up in fatty liver patients. Dig Dis 2010;28:709-714
7. Jones CI, Newbury SF: Functions of microRNAs in Drosophila development. Biochem Soc Trans 2010;38:1137-1143
8. Chen J, Wang DZ: microRNAs in cardiovascular development. J Mol Cell Cardiol 2012;52:949-957
9. Jansson MD, Lund AH: MicroRNA and cancer. Mol Oncol 2012;6:590-610
10. Amiel J, de Pontual L, Henrion-Caude A: miRNA, Development and Disease. Adv Genet 2012;80:1-36
11. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98
12. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ: Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008;48:1810-1820
13. Zheng L, Lv GC, Sheng J, Yang YD: Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-Alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 2010;25:156-163
14. Williams MD, Mitchell GM: MicroRNAs in insulin resistance and obesity. Exp Diabetes Res 2012;2012:484696
15. Li P, Jiao J, Gao G, Prabhakar BS: Control of mitochondrial activity by miRNAs. J Cell Biochem 2012;113:1104-1110
16. Tang H, Lee M, Sharpe O, Salamone L, Noonan EJ, Hoang CD, Levine S, Robinson WH, Shrager JB: Oxidative stress-responsive microRNA-320 regulates glycolysis in Diverse biological systems. FASEB J 2012;26:4710-4721
17. Sen CK, Roy S: MicroRNA 21 in tissue injury and inflammation. Cardiovasc Res 2012;96:230-233
18. Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM: Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Digest Dis2008;9:108-112
19. Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell J V, O'Connor JE: A human hepatocellular in vitro model to investigate steatosis. Chem-Biol Inter 2007;165:106-116
20. Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, De Munter S, Prawitt J, Caron S, Staels B, Van Vlierberghe H, Van Gaal L, Geerts A : Evaluation of inflammatory and angiogenic factors in patients with non-Alcoholic fatty liver disease. Cytokine 2012;59:442-449
21. Fredriksson L, Herpers B, Benedetti G, Matadin Q, Puigvert JC, de Bont H, Dragovic S, Vermeulen NP, Commandeur JN, Danen E, de Graauw M, van De Water B: Diclofenac inhibits tumor necrosis factor-Alpha-induced nuclear factor-kappaB activation causing synergistic hepatocyte apoptosis. Hepatology 2010;53:2027-2041
22. Sun H, Zhang Y, Gao P, Li Q, Sun Y, Zhang J, Xu C: Adiponectin reduces C-reactive protein expression and down-regulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. Mol Cell Biochem 2011;347:183-189
23. Birney E, Stamatoyannopoulos JA, Dutta A, the ENCODE Project Consortium: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447:799-816
24. Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, Bumgarner RE, Bushel PR, Chaturvedi K, Choi D, Cunningham ML, Deng S, Dressman HK, Fannin RD, Farin FM, Freedman JH, Fry RC, Harper A, Humble MC, Hurban P, Kavanagh TJ, Kaufmann WK, Kerr KF, Jing L, Lapidus JA, Lasarev MR, Li J, Li YJ, Lobenhofer EK, Lu X, Malek RL, Milton S, Nagalla SR, O'malley JP, Palmer VS, Pattee P, Paules RS, Perou CM, Phillips K, Qin LX, Qiu Y, Quigley SD, Rodland M, Rusyn I, Samson LD, Schwartz DA, Shi Y, Shin JL, Sieber SO, Slifer S, Speer MC, Spencer PS, Sproles DI, Swenberg JA, Suk WA, Sullivan RC, Tian R, Tennant RW, Todd SA, Tucker CJ, Van Houten B, Weis BK, Xuan S, Zarbl H: Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005;2:351-356
25. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D: Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Systems Biol 2007;3:89
26. Mukherjee S, Berger MF, Jona G, Wang XS, Muzzey D, Snyder M, Young RA, Bulyk ML: Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays. Nat Genet 2004;36:1331-1339
27. Deutscher D, Meilijson I, Kupiec M, Ruppin E: Multiple knockout analysis of genetic robustness in the yeast metabolic network. Nat Genet 2006;38:993-998
28. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010;38:D355-360
29. Wang K, Li M, Gao F, Li S, Zhu Y, Yang P: Identification of Conserved and Novel microRNAs from Liriodendron chinense Floral Tissues. PLoS One 2012;7:e44696
30. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401-1414
31. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP: Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010;24:992-1009
32. Jin X, Ye YF, Chen SH, Yu CH, Liu J, Li YM: MicroRNA expression pattern in Different stages of nonalcoholic fatty liver disease. Dig Liver Dis 2009;41:289-297
33. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ: Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008;48:1810-1820
34. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NFkappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103:12481-12486
35. Nielsen LB, Wang C, Sorensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB: Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012;12:896362
36. Schenk S, Saberi M, Olefsky JM: Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008;118:2992-3002
37. Klein C, Wustefeld T, Assmus U, Roskams T, Rose-John S, Muller M, Manns MP, Ernst M, Trautwein C: The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 2005;115:860-869
38. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P: Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006;44:1167-1174
39. Wilfred DAN, Day CP: Genes and nonalcoholic fatty liver disease. Curr Diab Rep 2008;8:156-163
40. Day CP: Genetic and environmental susceptibility to non-Alcoholic fatty liver disease. Dig Dis 2010;28:255-260
41. Fan JG, Qiao L: Commonly used animal models of non-Alcoholic steatohepatitis. Hepatobiliary Pancreat Dis Int 2009;8:233-240
42. Hoen PA, Ariyurek Y, Thygesen HH, Vreugdenhil E, Vossen RH, de Menezes RX, Boer JM, van Ommen GJ, den Dunnen JT: Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res 2008;36:e141
43. Alisi A, Da SL, Bruscalupi G, Piemonte F, Panera N, De Vito R, Leoni S, Bottazzo GF, Masotti A, Nobili V: Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 2011;91:283-293
44. Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA: Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 2010;90:1437-1446
45. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2010;103:12481-12486
46. Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A, Szabo G: MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 2009;33:1704-1710
47. Marra F, Bertolani C: Adipokines in liver diseases. Hepatology 2009;50:957-969
48. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA: Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003;278:13740-13746
49. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B: The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007;120:3045-3052
50. Teng Y, Mei Y, Hawthorn L, Cowell JK: WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene 2014;33:203-211
51. Rizzo R, Farina I, Bortolotti D, Baricordi OR, Farina I, Padovan M, Govoni M: Can HLA-G predict disease course in rheumatoid arthritis patients?. Int J Clin Rheumatol 2013;8:627-638
52. Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, Fang L, Yan X, He M, Li J, Li M: MicroRNA-30e promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/ IkappaBalpha negative feedback loop. J Clin Invest 2012;122:33-47
53. Mihelich B L, Khramtsova E A, Arva N: miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells[J]. J Biol Chem 2011;286:44503-44511
54. Latronico MVG, Condorelli G: microRNAs in hypertrophy and heart failure. Exp Biol Med 2011;236:125-131